berberine has been researched along with glycolipids in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guang, LX; Li, DD; Tang, JL; Xu, Y; Ying, Y; Zhang, KB; Zhang, L; Zhou, JY; Zhou, SW | 1 |
| Ai, W; Duan, Y; Kuang, H; Li, D; Li, M; Li, W; Liu, S; Liu, X; Shao, M; Wang, Y; Xu, Y | 1 |
| Chen, X; Hu, H; Li, P; Rao, Y; Shen, Y; Sun, Y; Yang, X; Zou, Y | 1 |
| Jia, Q; Li, J; Li, M; Liu, Y; Qiu, Y; Zhang, J; Zhang, Y; Zhao, Y | 1 |
1 trial(s) available for berberine and glycolipids
| Article | Year |
|---|---|
The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Antipsychotic Agents; Berberine; Double-Blind Method; Glycolipids; Humans; Schizophrenia; Treatment Outcome | 2021 |
3 other study(ies) available for berberine and glycolipids
| Article | Year |
|---|---|
Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats.
Topics: Animals; Berberine; Blood Glucose; Body Weight; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Fatty Liver; Glycated Hemoglobin; Glycolipids; Hyperlipidemias; Immunohistochemistry; Liver; Liver Glycogen; Male; Organ Size; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Wistar | 2008 |
The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.
Topics: Adult; Anti-Inflammatory Agents; Anti-Mullerian Hormone; Berberine; Cells, Cultured; Female; Glycolipids; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukins; Polycystic Ovary Syndrome; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Berberine; Biofilms; Glycolipids; Helicobacter Infections; Helicobacter pylori; Mice | 2020 |